The effect of curcumin and vitamin E on hot flush and anxiety in postmenopausal wome

Phase 2

Recruiting

Conditions: Condition 1: hot flush. Condition 2: anxiety.
Menopausal and female climacteric states
Anxiety disorder, unspecified

Registration Number: IRCT20120718010324N44

Lead Sponsor: Tabriz University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: Female

Target Recruitment: 93

Inclusion Criteria

Willingness to participate in the study
Having sufficient literacy to complete the questionnaire or the presence of a literate person in the family
Normal menopause
Being married
Women who have been under 6 years old since their menopause.
Having at least 40 years and a maximum of 60
Having hot flush at least twice a week

Exclusion Criteria

Use of tobacco and alcoholic beverages and herbal medicines
Stressful factors such as the death of relatives in the first six months of the past and loss of occupation
Known psychiatric or systemic problems including cardiovascular, digestive, liver, endocrine, etc.
Use of any effective medicines for hot flashes (Clonidine, Methyl dopa, Gabapentin, Selective Serotonin Reuptake Inhibitors (SSRIs), Norepinephrine inhibitors (SNRI), and Soy isoflavone
Factors that cause vasomotor disorder, such as thyroid disease, according to the person expression
Use of any effective medication to treat a person's sexual response (Antihypertensive, Thiazide diuretics, Antidepressant drugs such as Serotonin and Noradrenaline and Reuptake, Antihistamines, Barbiturates, Narcotics, Diazepam, Amphetamines, Cocaine
History of allergy to turmeric or other drugs, food and color
Taking anticoagulant drugs (Hyarin, Warfarin, Enoxaparin)

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Hot flush. Timepoint: Before the intervention, 4 and 8 weeks after the intervention. Method of measurement: Hot flush checklist.;Anxiety. Timepoint: Before the intervention, 4 and 8 weeks after the intervention. Method of measurement: State- Trait Anxiety Inventory.

Secondary Outcome Measures

Name	Time	Method
Sexual function. Timepoint: Before the intervention, 4 and 8 weeks after the intervention. Method of measurement: FSFI= Female Sexual Function Inventory.